The global clinical trial supplies market is poised to reach USD 6.3 billion by 2028 from USD 3.9 billion in 2023, at a CAGR of 9.9% during the forecast period.
Download Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172240059
This growth is driven by various factors such as increasing collaborations and partnerships among market players for clinical trial outsourcing services, a surge in R&D expenditure by biopharmaceutical and pharmaceutical companies, and a rising number of clinical trials conducted worldwide.
Understanding Clinical Trial Supplies Market Dynamics
Dominance of Logistics and Distribution Segment
In 2022, the logistics and distribution segment emerged as the dominant force in the clinical trial supplies market. This segment includes services such as logistics, distribution, storage, retention, packaging, labeling, blinding, manufacturing, comparator sourcing, and other ancillary supplies. The presence of prominent players offering clinical trial services is a significant driving factor for the growth of the logistics and distribution segment during the forecast period.
Oncology Leads the Disease Type Segment
The oncology segment holds the largest share of the disease type segment in the clinical trial supplies market. It is also the fastest-growing segment. The increasing demand for cancer medicines has led to a rise in research for innovative drugs and development. Moreover, pharmaceutical and biotechnology companies are investing significantly in R&D for new drug development, further boosting the oncology segment's growth.
Rapid Growth in the Asia Pacific Region
The Asia Pacific region is experiencing the fastest growth in the clinical trial supplies market. This growth can be attributed to several factors, including an emphasis on strategic initiatives such as partnerships, collaborations, and expansions, as well as a growing influx of investments in the life sciences sector. The region is witnessing a large number of clinical trials, with countries like India and China leading the way. For instance, according to the World Health Organization (WHO), India registered the highest number of clinical trials in the Asia Pacific region and globally, with around 9,954 clinical trials registered, while China registered around 5,465, making it the third-largest in the world.
Key Market Players
The clinical trial supplies market is consolidated, with a small number of players competing for market shares. Some of the leading players in this market include:
- Thermo Fisher Scientific Inc. (US)
- Catalent, Inc. (US)
- Eurofins Scientific (France)
- Piramal Pharma Solutions (India)
- PRA Health Sciences (US)
- Marken (A Subsidiary of UPS) (US)
- Parexel International (MA) Corporation (US)
- Biocair (UK)
- AlmacGroup (UK)
- Sharp Services, LLC (US)
- PCI Pharma Services (US)
- Nuvisan (Germany)
- Lonza Group (Switzerland)
These companies are focusing on organic and inorganic growth strategies such as service launches, expansions, acquisitions, partnerships, agreements, and collaborations to increase their service offerings, cater to the unmet needs of customers, increase profitability, and expand their global presence.
Request Sample Pages: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172240059
Conclusion
The clinical trial supplies market presents significant opportunities for growth, driven by increasing R&D activities in the pharmaceutical and biotechnology sectors, rising demand for innovative drugs, and a surge in the number of clinical trials conducted globally. With a focus on innovation and strategic partnerships, market players are well-positioned to capitalize on these opportunities and drive further advancements in the field of clinical trial supplies.
